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Background: Vibrio cholerae serogroup O1 has two major serotypes, Ogawa and Inaba, which may alternate
among cholera epidemics. The rfbT gene is responsible for the conversion between the two serotypes. In this study,
we surveyed the sequence variance of rfbT in the Ogawa and Inaba strains in China over a 48-year (1961-2008)
period in which serotype shifts occurred among epidemic years.
Results: Various mutation events including single nucleotide, short fragment insertions/deletions and transposases
insertions, were found in the rfbT gene of the Inaba strains. Ectopically introducing an intact rfbT could overcome
the mutations by converting the Inaba serotype to the Ogawa serotype, suggesting the effects of these mutations
on the function of RfbT. Characteristic rfbT mutations were recognized in the Inaba strains among Inaba serotype
dominant epidemic years which were separate from the Ogawa dominant epidemics. Three distinguishable
mutation sites in rfbT between the classical and the El Tor biotype strains were identified and could serve as
biotype-specific biomarkers.
Conclusions: Our results provide a comprehensive picture of the rfbT gene mutations among the V. cholerae O1
strains in different epidemic periods, which could be further used as the tracing markers in clonality analysis and
dissemination surveillance of the epidemic strains.Background
Cholera is a severe disease characterized by watery diar-
rhea that is caused by the gram-negative bacterium V.
cholerae. The massive diarrhea experienced by patients
is mainly due to the colonization of toxigenic V. cholerae
strains in the small intestine and their production of
cholera toxin (CT) [1]. Cholera continues to be a major
public health concern in many developing countries
[2,3]. Outbreaks of cholera have been increasing globally
in the past decade, most recently in Haiti [4].* Correspondence: kanbiao@icdc.cn
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reproduction in any medium, provided the orV. cholerae is naturally present in the environment
and autochthonous to coastal and estuarine ecosystems.
Based on the heat-stable somatic O antigen, the species
V. cholerae is divided into more than 200 serogroups
[5,6]. Only two serogroups, O1 and O139, have thus far
been demonstrated to cause epidemic and pandemic
cholera. Seven pandemics caused by V. cholerae O1 have
been reported since 1871. V. cholerae O139 emerged in
late 1992 on the India subcontinent [7,8]. V. cholerae O1
exists as two biotypes, classical and El Tor, which are
distinguished by a variety of phenotypic markers, and
differ in the severity of their infections and ability to sur-
vive outside the human intestine as well [3,9-11]. Two of
the first six cholera pandemics are known to have been
caused by the classical biotype, while the ongoing sev-
enth pandemic, which began in 1961, is caused by the El
Tor biotype.
The vast majority of strains within the O1 serogroup
display one of two serotypes, Ogawa or Inaba. A thirdtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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stable and not recognized by some authorities [3]. The
Ogawa and Inaba serotypes differ by the presence of a 2-
O-methyl group in the nonreducing terminal carbohy-
drate in the Ogawa O antigen [12,13]. The O antigen is
not a primary gene product, but rather, an assemblage of
sugar moieties. The genes responsible for the synthesis
of the O1-specific antigens are present in a cluster desig-
nated the rfb region [14]. Genetic changes in this region
are correlated with specific somatic antigens which are
serologically different. The serogroup O139 resulted
from a 22 kb deletion of the rfb region of an O1 El Tor
strain, with replacement by a 35 kb wbf region encoding
the O139 specific O antigen [15].
Serotype conversion within the O1 serogroup has been
demonstrated to occur during subculture in vitro, pas-
sage in vivo, epidemics and during phage treatment
[16-21]. Genetic alterations in the rfbT gene account for
the serotype shift which encodes a transferase respon-
sible for the expression of the Ogawa-specific antigen
[19,22,23]. Site-specific sequence mutations causing a
frameshift in the rfbT gene, thus producing truncated
RfbT proteins, were previously detected in Inaba strains
[19,22,24]. Generally, the serotype shift occurs more fre-
quently in the direction of Ogawa to Inaba [3]. Experi-
mentally providing the intact rfbT gene can convert the
Inaba serotype to the Ogawa serotype, but this cannot
be achieved during the natural infection process. Theor-
etically, one Ogawa strain may arise from the reversion
of an original mutation, but the correction of the specific
substitution or deletion is necessarily a rare event [3,22].
Mutations in rfbT were used to assess the clonal origin
and dissemination of clinical Inaba isolates [24]. The
serotype shift pattern of cholera in endemic areas was
also historically observed [25,26] and indicated to be as-
sociated with high, but incomplete, cross-immunity be-
tween the Ogawa and Inaba serotypes [20].
Continuous surveys on the Inaba strains may reveal
more mutations of the rfbT gene, and even clonality of
the epidemic V. cholerae strains. In China the seventh
cholera pandemic caused by O1 El Tor V. cholerae
started in July 1961 [27]. Notifiable cases of cholera
reported to the national disease surveillance and
reporting system showed that there were serotype shifts
during the years of El Tor biotype epidemics. In this
study, diversity of the rfbT sequence and the effect of the
rfbT mutations on the serotyping were investigated.
Characteristic mutations causing serotype shifts in dif-
ferent Inaba predominant epidemics were observed.
Methods
Bacteria strains, media and plasmids
This study was conducted on 134 O1 El Tor and 1 O1
classical V. cholerae strains isolated from differentprovinces in China from 1961 to 2008,together with 18
laboratory-collected O1 classical strains and 10 O1 El
Tor strains isolated outside of China (Additional file 1:
Table S1). All strains were recovered from −80°C labora-
tory stocks. Slide agglutination tests were used to sero-
type the strains using anti-Ogawa and anti-Inaba
monoclonal antibodies (S&A reagents lab, Bangkok,
Thailand). Classical biotype strains were further con-
firmed using the Classical IV bacteriophage susceptibility
assay [28] and the polymyxin B (50U) susceptibility assay
with V. cholerae 569B and N16961 used as reference
strains. The pBR322 plasmid was used as the cloning
vector. Suicide plasmid pCVD442 was used to engineer
mutations in host strains via allelic exchange. Escherichia
coli strain Top10 and SM10λpir were used as the recipient
strains. All strains were grown in Luria-Bertani (LB) broth
or Luria-Bertani (LB) agar plates at 37°C. Ampicillin
was used at a final concentration of 100 μg/ml when
necessary.
PCR amplification and construction of complementary
plasmid
PCR amplification was carried out using standard proto-
cols with rfbt-up (5′ GCG TCG ACG AAT CGG CAG
TCG CAA CA 3′) and rfbt-dn (5′ CCC AAG CTT
CAA AGC TAT ACT AAA CTG 3′) primers. A water-
boiled template of each strain was used. The 1441 bp
PCR products were purified with a QIAGEN PCR purifi-
cation kit (Qiagen Inc., Hilden, Germany) and applied
for commercial sequencing. The nucleotide and deduced
protein sequences were analyzed with the MegAlign pro-
gram included in the DNASTAR software package
(DNA Star Inc., Madison, WI). The PCR product of rfbT
from Ogawa strain O395 was cloned into pBR322 after
gel purification and cleavage with SalI and HindIII. The
resulting plasmid, pBR322-rfbT, expressed the rfbT gene
from its own promoter.
Construction of mutant
T472C substitution mutant was constructed by allelic
exchange using Ogawa strain 7743 as a wild-type precur-
sor which was an ideal natural vaccine candidate strain
selected in our laboratory previously [29,30]. The target
sequences was amplified with primer pair rfbT-472C-up-
SalI/rfbT-472C-dn-SacI (5′ AAC GTC GAC GAG GTA
GTA ATG AAA CAT CT 3′/5′ CGA GCT CAG GAA
TTC ACA GCA CAT C 3′, in which the nucleotides in
italics indicate the restriction sites) using strain ZJ05023
as the template which contains T472C substitution on
the chromosomal rfbT gene. The 978 bp amplification
product was directionally cloned into pUC19 using E. coli
TOP10 as the host and confirmed by sequencing of
both DNA strands with M13 forward and reverse primers.
The corresponding SalI/SacI fragment was subsequently
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suicide plasmid was constructed in E. coli SM10λpir and
mobilized into Ogawa strain 7743 by conjugation.
Exconjugants were selected on LB agar containing PolB
(100 unit/ml) and Amp (150 μg/ml) and streaked on LB
agar containing 15% (w/v) sucrose. Sucrose-resistant col-
onies were tested for Amp sensitivity and then screened
for serotype conversion with slide agglutination tests. The
colonies displaying Inaba serotype was confirmed by DNA
sequencing using primers rfbT-472C-up-SalI and rfbT-
472C-dn-SacI.
Gene complementation
rfbT complementation tests were performed by introdu-
cing the rfbT-expressing plasmid pBR322-rfbT into se-
lected V. cholerae Inaba strains by electroporation as
described by Chiang and Mekalanos [31]. Overnight cul-
tures from fresh single colonies were subcultured 1:100
in LB and grown to mid-log phase at 37°C on a roller
shaker. Cells from 5 ml of a mid-log-phase culture were
washed three times in 2.5 ml of ice-cold 2 mM CaCl2,
and then resuspended in 100 μl of ice-cold 2 mM CaCl2.
The electroporated cells were recovered at 30°C for 2 h
without shaking and plated on LB agar containing ampi-
cillin (100 μg/ml). Colonies from each electroporation
were re-streaked on LB agar containing ampicillin and
used to screen for serotype conversion with slide agglu-
tination tests.
Pulsed-field gel electrophoresis (PFGE)
The PFGE analysis was conducted as described in the
literature [32]. Briefly, cell suspensions were adjusted to
an optical density of 4.0–4.2 using the Densimat pho-
tometer (BioMérieux, Marcy l’Etoile, France). Agarose
plugs were prepared, and the organisms in the plugs
were digested using 20 U per slice of NotI. Electrophor-
esis was performed using a CHEF-DRIII system (Bio-Rad
Laboratories, Hercules, CA). The BioNumerics software
package (version 4.0; Applied Maths, Inc.) was used to
analyze the PFGE patterns. A dendrogram was produced
using the Dice coefficient and the unweighted-pair group
method with an arithmetic mean algorithm (UPGMA)
with a position tolerance of 1.3%.
Nucleotide sequences and accession numbers
The rfbT genes with sequence variation from the Chinese
strains were deposited in the NCBI database under
accession numbers JX565645-JX565687, respectively.
The rfbT sequences of strains N16961 [33], MJ-1236
[34], M66-2 [35], 2010EL-1786 [36], RC9 (accession
number ACHX01000006.1), B33 [34], CIRS101 [34],
IEC224 [37], LMA3984-4 [38] and NIH35A3 (accession
number X59779) were downloaded from the NCBI
database.Results
Serotype shifts during the cholera epidemics in China
Based on the surveillance data, cholera epidemics in
China can be recognized as occurring in three different
periods, with peaks of reported cases in 1962, 1980 and
1994, and the intervening periods respectively [39,40].
As shown in Figure 1, the Ogawa serotype dominated
during the first epidemic period from 1961 to 1964,
while the Inaba dominated the second epidemic period
from 1978 to 1989. During the third epidemic period
from 1993 to 2000, Ogawa reemerged as the dominant
serotype, although a new serogroup, O139, emerged in
1993. Each transition of the dominant serotype was
followed by the appearance of a new epidemic peak.
After 2000, cholera subsided to a very low level of epi-
demic, but serotype shifts were still observed. The Inaba
serotype significantly increased in 2001 and 2002 after
having almost disappeared for ten years. The Inaba sero-
type upsurged in 2005 and decreased in 2006.
Sequence variations in Ogawa serotype strains
A previous study with a very limited number of strains
showed no significant sequence mutations in the Ogawa
serotype [22]. Here we sequenced the rfbT genes of 71
Ogawa isolates, including 6 classical strains and 65 El
Tor strains (Additional file 1: Table S1). Except strains
6310, 6312 and 63–12 (from Indonesia), 863 (from
Mauritania) and C7258 (from Peru), the El Tor strains
were isolated from 13 different provinces in China over
a 44-year period. In addition, the rfbT sequences of four
whole genome-sequenced Ogawa strains, M66-2 (from
Indonesia in 1937, a pre-seventh pandemic strain) [35],
B33 (from Mozambique in 2004) [34], RC9 (from Kenya
in 1985, accession number ACHX01000006) and 2010EL-
1786 (from Haiti in 2010) [36], were retrieved from the
NCBI database. The ORF of rfbT (Vch1786_I2540) in
2010EL-1786 was recognized as a fragment of 903bp in its
annotation file. After carefully examined the sequence, we
revised the sequence by removing the additional 42 bps
from the 5′ side (positions 2687324–2687365 in the gen-
omic sequence of NC_016445.1) in our analysis.
The sequence alignments of 75 Ogawa strains revealed
high homology in rfbT nucleotide sequence except for
three sites which were different, but conserved be-
tween classical and El Tor biotypes respectively. All
69 El Tor biotype Ogawa strains had identical se-
quences. Compared with the sequences of El Tor biotype,
substitutions of T for G at position 137 (G137T),
TACA303-306ACAC (as the result of T-303 deletion and
a C insertion after C-307 in the classical Ogawa strains)
and C487A were found in all six classical Ogawa strains
(Additional file 2: Figure S1), which resulted in amino acid
changes of W46L, T102H and Q163K, respectively. Strain
16503 has another mutation G456A compared with all
Figure 1 Reported cases in the cholera surveillance of China and the dominant serotypes of V. cholerae O1 strains during the different
epidemic years.
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type, we inferred that these non-synonymous mutations
did not affect the function of the RfbT transferase.
Sequence variations in Inaba serotype strains
We sequenced rfbT of 74 Inaba isolates from 19 prov-
inces during the 1961–2008 epidemics in China, to-
gether with 18 Inaba strains isoloated outside of China
(Additional file 1: Table S1). Totally there are 14 classical
Inaba strains. Additionally, the sequence of rfbT in clas-
sical Inaba strain NIH35A3 (accession number X59779)
and five other whole genome-sequenced El Tor Inaba
strains including N16961 [33], IEC224 [37], MJ-1236
[34], CIRS101 [34] and LMA3984-4 [38]) were obtained
from GenBank genome database and added to the
comparison. The rfbT gene (VCD_001363) of MJ-1236
was recognized as a shorter fragment of 819 bp in
its annotation file, we revised the sequence by includ-
ing a 49 nucleotide region exactly located in the up-
stream of the originally recognized start codon “TTG”
(positions 375973–376021 in the genomic sequence of
CP001485.1) in our analysis after sequence examin-
ation and alignment.
The sequence comparison of rfbT from totally 98
Inaba strains revealed multiplex mutational events
(Table 1), which had occurred in 21 positions along the
rfbT gene. One type of mutation was transposable elem-
ent mediated. Specifically, an ISVch5 transposase was
inserted at the C49TTG site of the rfbT sequence in
strain SD95001, with the 4-bp insertion sequence dupli-
cation. A transposase OrfAB gene element was inserted
in the rfbT genes of strains N16961, IEC224, LMA3984-4 and GX06002. The transposase OrfAB gene contains
two partially overlapping open reading frames, with 8 bp
terminal inverted repeats (TGTAGTGG/CCACTACA)
(Figure 2). It was uniquely inserted at the A189AAC site
of the rfbT coding sequence in N16961, IEC224 and
LMA3984-4. In contrast in the GX06002 strain, it was
reversely inserted at the A41AAC site. Both insertion
events duplicated the target sequence which flanked at
both sides of transposase OrfAB (Figure 2).
Other sequences variations were due to nucleotide
mutations, including deletions, insertions and base sub-
stitutions (Table 1). Compared to the El Tor biotype
Ogawa strain B33, 39.8% (39/98) of the analyzed Inaba
strains exhibited single nucleotide mutations (deletion,
insertion or substitution) at different positions of the
rfbT gene which caused a frameshift and resulted in
truncated RfbT proteins. Additionally, three particular
mutations at positions 137, 472 and 487 were found to
cause non-synonymous mutations. The substitutions of
G137T and C487A in all 14 classical Inaba strains, com-
pared to the rfbT sequence of El Tor Ogawa strain B33,
resulted in a replacement of W46L and Q163K, respect-
ively, the same as had been found in the classical Ogawa
strains (Additional file 2: Figure S1). The substitution of
T472C of rfbT in strains FJ05234, ZJ05023, FJ147,
GD05039, HL08091 and CIRS101 resulted in a change
of S158P of RfbT, which is the only single mutation
found in these strains and suggests that a Ser residue at
this position is critical for the function of the RfbT
transferase. Another important site is position 482, for
the resulting Y161 to F substitution determined Inaba
phenotype in XJ05021 too.
Table 1 Nucleotide sequence changes in the rfbT gene of different Inaba strains of V. cholerae O1 El Tor relative to El
Tor Ogawa strain B33
Mutational event Change(s) Strain(s) Consequence
Transposase insertion Transposase inserted at 5′
region of rfbT
N16961, IEC224, LMA3984-4, GX06002*, SD95001* RfbT inactivation
Single nucleotide
mutation
G-3 to A ZJ011319*, GD01049, CQ02057, GX01012, JX01002, LN01-1,
CQ01008
114 amino acids of
N-terminal untranslated
A-20 deleted ZJ05070 Frameshift: K6NYVQKL to
K6TMYKN-Stop
A inserted after G-55 XJ7517, XJ81759* Frameshift: D18AIQSKSVHD
to D18 DYSVKVCS-Stop
G −137 to T 569B§, 16510§, 16186§, 16177§, 16159§, 16156§, 16148§,
1119§, 16020§, 16002§, 16121§, 16505§, 16507§, NIH35A3§
RfbT W46 to L
T-303 deleted 569B§, 1119§, 16020§, 16002§, 16505§, 16507§ RfbT T102 to H
C inserted after C-307 569B§, 1119§, 16020§, 16002§, 16505§, 16507§





C-307 to T E506 Frameshift: T102Q to T102-Stop
T-472 to C FJ05234*, ZJ05023, GD05039, HL08091, FJ147, CIRS101 RfbT S158 to P
A-482 to T XJ05021* RfbT Y161 to F
C-487 to A 569B§, 16510§, 16186§, 16177§, 16159§, 16156§, 16148§,
1119§, 16020§, 16002§, 16121§, 16505§, 16507§, NIH35A3§
RfbT Q163 to K
A-494 deleted 16020*§, 16002§, 16505§, 16507§, 16121§, 1119§; GX00107*,
XJ05021*, GD91070, GD06119, GD06009, JX04043, GX06021
Frameshift: K164NTDI to
K164IQT-Stop (16121 yields
truncated proteins due to
nonsense mutations at 307nt)
A-495 deleted V01, C6706, X190 Frameshift: K164NTDI to
K164IQT-Stop
C-563 to A TJ64600, JS32*, BJ6588, Frameshift: I187S to I187-Stop
G-655 to T 569B§ Frameshift: N218G to N218-
Stop
C-785 to A LN04060 Frameshift: L261S to L261-Stop
Multiple nucleotides
mutation
TGATGCT inserted after T-57 MJ1236 Frameshift: A19I to A19-Stop
TATG insterted after G-207 T21 Frameshift: M69RHWIVNH to
M69YASLDC-Stop
GACACAT inserted after T-237 HE65441*, BJ84203, JX8672, JS63257 Frameshift: T81T to T81-Stop
GCTGAACATCC deleted after
C-789
BJ821*, JX801361, BJ83801, FJ85063, HN8232, JS80269,
JX801360, SD83101, AH88602, FJ86104, HN81331, JX801309,
JX801363, BJ83795, JS80215, JX801305, JX84172, JX8788,
SD83163, SD83164, SD83167, SX8429, JX801342, HN84345,
FJ80004, GD791080, GD791084, GD861812, HN81175,
JX801295, JX8659, JX87123, SC83535, ZJ861071, FJ8004,
JX84190, LN85092, SD83176, JX801290, JS80252, FJ85010,
ZJ82428
Frameshift: S263A to S263-Stop
* the strain selected as the representative of the different kinds of mutations and examined the seroconversion in complement assay by inducing a
rfbT- expressing plasmid, pBR-rfbT.
§ classical biotype.
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in all 14 classical Inaba strains, but caused two different
mutations (Table 1, Additional file 2: Figure S1). In
strains 16121, 16148, 16510, 16186, 16177, 16159,
16156, and NIH35A3, this insertion caused a frameshift
mutation, subsequently formed an internal stop codon
after position 348, leading to premature termination ofRfbT translation. Whereas in strains 569B, 1119, 16020,
16002, 16505 and 16507, the reading frame was
maintained since this insertion was counteracted by the
prior deletion at position 303. The combined effect of
the two sites of mutations led to the replacement of
T102H in these strains. The Inaba phenotype of theses
strains resulted from the truncated RfbT caused by an
Figure 2 The sequence alignment of the transposase OrfAB insertion regions in the rfbT gene. The 8-bp terminal inverted repeats are
underlined; possible duplicated AAAC insertion sequences are italicized and in bold; the ORFs of the transposase OrfAB element are shown by
hollow arrows with the indicated start and end codons.
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the posterior sequence. Strains V01, C6706, X190 which
were isolated from South America had identical single
nucleotide mutation different from E506 isolated from
America. In addition, 48.0% (47/98) of the strains were
noted to have short-sequence indels (insertions/dele-
tions) resulting in truncated and prematurely-terminated
RfbT proteins.
Characteristic mutations of Inaba strains in the Inaba
dominant epidemics in China
During the cholera epidemics from 1961 to 2008 in
China, Ogawa/Inaba serotype shifts were observed.
Three Inaba serotype dominant multiyear epidemics
occurred in 1976–1989, 2001–2002 and around 2005.
In this study, most (42/45) Inaba strains isolated in
1979–1988 displayed the identical mutation of 11-bp
(GCTGAACATCC) deletion (Figure 3). These strains
were isolated from 11 different provinces, and were
characterized with the marker mutation of rfbT in the
epidemics (Table 1). PFGE subtyping on 36 of these
41 strains (Additional file 3: Figure S2) showed that
17 strains possessed the same pattern, while other
patterns only displayed 1–3 band differences com-
pared to the predominant pattern, with similarity co-
efficient values of 93.0%-97.7%, indicating they were
closely related in terms of their genetic background.
Among three other strains, two showed GACACAT
insertion after T-237, one strain had an A insertion after
G-55, both caused the frameshift and truncated RfbT pro-
teins (Table 1). These rfbT mutations resulted in sporadic
Inaba strains in these epidemics.
During 2001–2002 Inaba serotype dominant epi-
demics, all test seven Inaba strains isolated from six
provinces had the same G3A substitution only, which
caused disappearance of the start codon (ATG) and thus
no translation of the 114 amino acid residues of RfbT
N-terminal (Table 1, Figure 3). Among the six Inabastrains isolated in the epidemic of 2005, four showed
predominant A472T mutation which resulted in S158P of
RfbT, whereas the other two strains (ZJ05070 and
XJ05021) had different mutations (Table 1, Figure 3). In
different Inaba serotype dominant epidemics the strains
had the individually predominant mutations within RfbT.
Different rfbT mutations were observed among the Inaba
strains in the non-Inaba-dominant years (Table 1,
Figure 3). The same rfbT mutations were sometimes
found in the Inaba strains isolated in the non-Inaba-
dominant years, even from different countries, such as
transposase insertion, A-494 deletion and GACACAT
insertion (Table 1), suggesting the hot spots of mutation,
or wide distribution of such strains.
Seroconversion of the Inaba strain containing a rfbT
expressing-plasmid and construction of T472 C
substitution mutant in Ogawa background
To determine the rfbT mutations observed in this study
were responsible for the serotyping, we induced the
seroconversion of Inaba strains by introducing the re-
combinant plasmid pBR-rfbT carrying intact rfbT gene.
Twelve Inaba strains which contained different frame-
shifts were selected. Agglutination of the transformed
strains with specific typing sera showed that all but one
(GX06002) had been converted from Inaba to Ogawa.
Interestingly, for strain GX06002, some transformed col-
onies were converted to Ogawa, while other colonies
maintained the Inaba serotype. One possible explanation
for this result may be the different copy numbers of the
plasmid in the host cells. Chiang et al. also reported that
the presence of one copy of rfbT on the chromosome is
not sufficient to restore the Ogawa serotype [31].
To further confirm that single point mutation only
causing non-synonymous mutation was truly involved in
the serotype shift, we performed the opposite experi-
ment, i. e. induction of Inaba serotype in Ogawa strains.
We created the T472C substitution on the chromosomal
Figure 3 Minimal spanning tree of 74 Inaba strains of O1 El Tor V. cholerae isolated in China based on the rfbT sequence. Subtypes are
indicated by circles, whose diameter increases as the number of strains increases. Colors were used to indicate the different time periods when
the strains were isolated. The strain names in different subtypes are shown in the corresponding circles except the one labeled A. Strains in circle
A were characterized with 11-bp deletion and isolated during the first Inaba dominated epidemic period (1979–1988). Circle A includes strain
BJ821, JX801361, BJ83801, FJ85063, HN8232, JS80269, JX801360, SD83101, AH88602, FJ86104, HN81331, JX801309, JX801363, BJ83795, JS80215,
JX801305, JX84172, JX8788, SD83163, SD83164, SD83167, SX8429, JX801342, HN84345, FJ80004, GD791080, GD791084, GD861812, HN81175,
JX801295, JX8659, JX87123, SC83535, ZJ861071, FJ8004, JX84190, LN85092, SD83176, JX801290, JS80252, FJ85010 and ZJ82428.
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combination. As expected, this substitution caused sero-
type shift from Ogawa to Inaba in strain 7743. Subsequent
introducing the recombinant plasmid pBR-rfbT carrying
intact the rfbT gene induced the seroconversion from
Inaba to Ogawa phenotype. Taken together, our study
experimentally demonstrated T472C substitution is truly
involved in the serotype shift.
Discussion
In this study, we presented the descriptive data regard-
ing cholera serotype-cycling in China over a 48-year
(1961–2008) period, and also noted the multiplicity of
rfbT sequence variations in V. cholerae O1 isolates.
Three single nucleotide substitutions and deletion muta-
tions of rfbT have been reported which caused serotype
switching due to a frameshift or crucial amino acid resi-
due change in RfbT [22,41,42]. In our study much more
mutations are found in the Inaba serotype strains, in-
cluding single amino acid residue substitutions, frame-
shifts caused by single nucleotide and short fragment
insertions/deletions, and transposition events. These
mutations occurred randomly over the entire open read-
ing frame of rfbT, which may suggest the mutationsoccurred frequently and differently under pressures from
environment and human immunity, as well as spontan-
eous mutation. With the complementation of the intact
rfbT gene, these Inaba strains were converted to the
Ogawa serotype, which validate the mutations on the
Inaba serotype conversion.
Our study provides the first evidence that mobile gen-
etic elements, including the transposase OrfAB and
ISVch5 transposase, are involved in inactivating the rfbT
of V. cholerae, thus contributing to the serotype inter-
conversion. The insertion of the two kinds of transposases
both led to duplication of the inserted sequence. Although
there is difference in terms of the insertion position
and orientation, the target sequence (AAAC) of the
transposase OrfAB elements in different strains was
the same. We further surveyed the distribution of
transposase OrfAB copies in several strains which
genome sequences are available. The copy number
and the distribution of transposase OrfAB on chro-
mosomes I and/or II vary in strains from different re-
gions and years. Strain N16961 contains six copies,
each chromosome harbors three copies. In IEC224, in
addition to the three copies on each chromosome,
there is an additional transposase OrfAB subunit B
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located on chromosome II. All these and our data suggest
that the transposase OrfAB is quite active in transposition
in V. cholerae, and probably has preferential insertion site
(s). For the first time, IS5 transposase was found to be in-
volved in the serotype conversion. Two copies of IS5
transposase are present on chromosome II of the N16961,
2010EL-1786, M66-2 and IEC224, while in strain
SD95001, the IS5 transposase inserts into the N-terminal
of the rfbT gene that was generally located on chromo-
some I.
The characteristic nucleotide polymorphisms are also
observed in the rfbT of the classical biotype and El Tor
biotype, irrespective of the serotypes. These include
G137T, C insertion after C-307 and C487A in all clas-
sical strains when compared to El Tor strains (reference
sequence is from El Tor Ogawa strain B33, Additional
file 2: Figure S1), which suggests that these sites in rfbT
could be used as nucleotide markers to differentiate both
biotypes, as has been shown for other gene alleles, such
as tcpA, rstR and ctxB [43-45].
In endemic areas of cholera, it has long been noticed
that the dominant serotypes tend to fluctuate, with shifts
occurring in the intervals between epidemics of the
disease [20,25]. A similar serotype conversion order
(Ogawa-Inaba-Ogawa) observed in Bangladesh was
found in China. The Ogawa serotype dominated in
the early period of the 1960s in China, consistent
with a report that the Ogawa serotype was the predomin-
ant serotype for a period before 1966 in Bangladesh [20].
The transition of Ogawa to Inaba occurred in 1978 in
China, 12 years later than the switch in Bangladesh. After
11 years when the Inaba serotype dominated (1978–1989),
the Ogawa serotype again took over the dominance in the
1990s. A similar trend in the prevalence of the Ogawa
serotype was also observed in India and Pakistan during
almost the same period [41,46].
Questions may raise about the mutations on rfbT among
the strains in the Inaba dominant epidemics. An 11-bp de-
letion event was found to be a distinguishable characteris-
tic of Inaba strains during the Inaba dominant ten year
period from 1979 to 1988, indicating that these strains
may have originated from a common ancestral clone with
this mutation, and then disseminated widely during the
second epidemic period in China. It was supported by the
PFGE fingerprints by showing same or highly similar
patterns of these strains, which may have been caused by
the minor variations accumulated gradually in such a
clone during its long epidemic history (Additional file 3:
Figure S2). Such deletion may be mediated by hom-
ologous recombination of a 5-bp repeat sequence
(CATCCGCTGAACATCC changed to CATCC, where
the nucleotides in bold indicate the sequence deleted,
and the italicized nucleotides are the repeated sequence).Predominant mutations of rfbT were also observed in
the Inaba strains during Inaba dominant epidemic years of
2001–2002 and 2005. Inaba strains in 2001–2002 had the
single nucleotide substitution which changed the start
codon ATG to ATA, complementation of intact rfbT into
such strain converted the serotype to be Ogawa, showing
the role of this nucleotide mutation. T472C was the only
nonsynonymous mutation that accounts for a serotype
shift in the Inaba strains in 2005, and we experimentally
demonstrated the critical role of a serine at this site for
the function of RfbT. The same single substitution was
also reported in the Inaba strains isolated during different
years (2005–2008) in Iran [42] and India [41].
Characteristic rfbT mutations occurred in different
Inaba serotype dominant epidemics, which may suggest
the clonality of the epidemic strains. These mutations can
be used as the sequence signatures in the clonal and evo-
lutionary analysis, and even the tracking markers in epi-
demiological investigations. Serotype conversion and
serotype-shifting in cholera epidemics have been thought
to be related to the immune response of individuals and
the immune status of the overall population, and has also
been documented in animal models [20,22,26]. Thereby it
could be deduced that in the cholera endemic regions rfbT
mutation will be an advantage for the spread of Inaba
strains following Ogawa serotype epidemic. In general, the
conversion of serotype from Ogawa to Inaba is easy to
occur, which is simply a rfbT mutant enrichment proced-
ure [22]. While the reciprocal serotype conversion, from
Inaba to Ogawa, is much more difficult considering the
requirement of the reversion of the original mutation and
the great variety of the rfbT genetic status of Inaba strains.
Maybe, the Inaba strains caused by transposase insertion
could be relatively liable to reverse to Ogawa phenotype
due to the active mobile ability of the insertion element.
Some strains were noticed to have accumulated multiple
mutations, it remains a puzzle if this represents a transi-
tional state of overcoming the original mutation by intro-
ducing the second or third mutation.
Conclusion
Our study presents the rfbT sequence variations of
V. cholerae O1 isolates during the serotype shifts
over a 48-year period in China. Different types of muta-
tional events and new mutation sites resulting in abnor-
mal translation of rfbT are observed, and characteristic
rfbT mutations in different Inaba serotype dominant epi-
demic periods are found. These distinguishable mutations
can be used as the tracing markers in the epidemic clone
analysis, and even surveillance for dissemination of spe-
cific clones. The rfbT mutation and subsequent serotype
shifts of the epidemic strains also could be considered as
one type of adaption to population immunity barrier in
the cholera endemic regions.
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Additional file 1: Table S1. Information of O1 V. cholerae strains used
in this study.
Additional file 2: Figure S1. The rfbT sequence alignment of the
mutation sites between the classical and El Tor biotypes. rfbT sequences
of all classical biotype strains were included in the analysis. For the El Tor
biotype strain, a representative sequence of the Ogawa serotype and
each mutation in the Inaba serotype are shown. The dots indicate
sequence identity. The nucleotides positions are shown. CVC and EVC
represent the classical and El Tor biotype V. cholerae strains, respectively.
* indicates the reconstructed rfbT in N16961 was used by removing the
insertion sequence of transposase orfAB.
Additional file 3: Figure S2. The results of the PFGE analysis using NotI
digestion of strains characterized by an 11-bp deletion mutation in rfbT.
The dendrogram was produced using the Dice coefficient and the
unweighted-pair group method with an arithmetic mean algorithm
(UPGMA) with a position tolerance of 1.3%.Abbreviations
CT: Cholera toxin; LB: Luria-Bertani; PFGE: Pulsed-field gel electrophoresis;
UPGMA: Arithmetic mean algorithm.
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